Dmitri Wiederschain

*This is an algorithmically generated author record based on publicly available information.

Research Subjects

Immunology

Research Interests

Dmitri Wiederschain has a total of 25 co-authors. Here are the top co-authors by number of shared publications:

Abha Dhaneshwar
Jounce Therapeutics, Cambridge, United States
54 shared publications
Alexa Diiorio
Jounce Therapeutics, Cambridge, United States
54 shared publications
Allison Goodman
Jounce Therapeutics, Cambridge, United States
54 shared publications
Amy Mueller
Jounce Therapeutics, Cambridge, United States
54 shared publications
Ben Umiker
Jounce Therapeutics, Cambridge, United States
54 shared publications
Christina Meyer
Takeda Oncology, Cambridge, MA, United States
54 shared publications

Latest Publications

Sort by

Open Access
Website
Google Scholar
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Figure S7 from Inhibition of LILRB2 by a Novel Blocking Antibody Designed to Reprogram Immunosuppressive Macrophages to Drive T-Cell Activation in Tumors
by Ben Umiker, Yasmin Hashambhoy-Ramsay, Jeff Smith, Tanzila Rahman, Amy Mueller, Rachel Davidson, Christina Meyer, Gayatri Patankar, Mohammad Murshid Alam, Sarah Jaffe, et al.
A set of 23 anti-LILRB2 antibodies were tested for their ability to block HLA-G tetramer binding to LILRB2 and induce TNF alpha in a macrophage activation assay.
Website
Google Scholar
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Open Access
Figure S7 from Inhibition of LILRB2 by a Novel Blocking Antibody Designed to Reprogram Immunosuppressive Macrophages to Drive T-Cell Activation in Tumors
by Ben Umiker, Yasmin Hashambhoy-Ramsay, Jeff Smith, Tanzila Rahman, Amy Mueller, Rachel Davidson, Christina Meyer, Gayatri Patankar, Mohammad Murshid Alam, Sarah Jaffe, et al.
A set of 23 anti-LILRB2 antibodies were tested for their ability to block HLA-G tetramer binding to LILRB2 and induce TNF alpha in a macrophage activation assay.
Open Access
Website
Google Scholar
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Figure S3 from Inhibition of LILRB2 by a Novel Blocking Antibody Designed to Reprogram Immunosuppressive Macrophages to Drive T-Cell Activation in Tumors
by Ben Umiker, Yasmin Hashambhoy-Ramsay, Jeff Smith, Tanzila Rahman, Amy Mueller, Rachel Davidson, Christina Meyer, Gayatri Patankar, Mohammad Murshid Alam, Sarah Jaffe, et al.
Example gating strategy for blood monocytes
Website
Google Scholar
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Open Access
Figure S3 from Inhibition of LILRB2 by a Novel Blocking Antibody Designed to Reprogram Immunosuppressive Macrophages to Drive T-Cell Activation in Tumors
by Ben Umiker, Yasmin Hashambhoy-Ramsay, Jeff Smith, Tanzila Rahman, Amy Mueller, Rachel Davidson, Christina Meyer, Gayatri Patankar, Mohammad Murshid Alam, Sarah Jaffe, et al.
Example gating strategy for blood monocytes
Open Access
Website
Google Scholar
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Figure S5 from Inhibition of LILRB2 by a Novel Blocking Antibody Designed to Reprogram Immunosuppressive Macrophages to Drive T-Cell Activation in Tumors
by Ben Umiker, Yasmin Hashambhoy-Ramsay, Jeff Smith, Tanzila Rahman, Amy Mueller, Rachel Davidson, Christina Meyer, Gayatri Patankar, Mohammad Murshid Alam, Sarah Jaffe, et al.
Example gating strategy in vitro differentiated GM-CSF and IL-4 Dendritic Cells
Website
Google Scholar
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Open Access
Figure S5 from Inhibition of LILRB2 by a Novel Blocking Antibody Designed to Reprogram Immunosuppressive Macrophages to Drive T-Cell Activation in Tumors
by Ben Umiker, Yasmin Hashambhoy-Ramsay, Jeff Smith, Tanzila Rahman, Amy Mueller, Rachel Davidson, Christina Meyer, Gayatri Patankar, Mohammad Murshid Alam, Sarah Jaffe, et al.
Example gating strategy in vitro differentiated GM-CSF and IL-4 Dendritic Cells
Open Access
Website
Google Scholar
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Figure S8 from Inhibition of LILRB2 by a Novel Blocking Antibody Designed to Reprogram Immunosuppressive Macrophages to Drive T-Cell Activation in Tumors
by Ben Umiker, Yasmin Hashambhoy-Ramsay, Jeff Smith, Tanzila Rahman, Amy Mueller, Rachel Davidson, Christina Meyer, Gayatri Patankar, Mohammad Murshid Alam, Sarah Jaffe, et al.
Changes in gene expression by JTX-8064 in both macrophages and dendritic cells 6 days on treatment during differentiation
Website
Google Scholar
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Open Access
Figure S8 from Inhibition of LILRB2 by a Novel Blocking Antibody Designed to Reprogram Immunosuppressive Macrophages to Drive T-Cell Activation in Tumors
by Ben Umiker, Yasmin Hashambhoy-Ramsay, Jeff Smith, Tanzila Rahman, Amy Mueller, Rachel Davidson, Christina Meyer, Gayatri Patankar, Mohammad Murshid Alam, Sarah Jaffe, et al.
Changes in gene expression by JTX-8064 in both macrophages and dendritic cells 6 days on treatment during differentiation
Open Access
Website
Google Scholar
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Figure S4 from Inhibition of LILRB2 by a Novel Blocking Antibody Designed to Reprogram Immunosuppressive Macrophages to Drive T-Cell Activation in Tumors
by Ben Umiker, Yasmin Hashambhoy-Ramsay, Jeff Smith, Tanzila Rahman, Amy Mueller, Rachel Davidson, Christina Meyer, Gayatri Patankar, Mohammad Murshid Alam, Sarah Jaffe, et al.
Example gating strategy in vitro differentiated M-CSF macrophages
Website
Google Scholar
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Open Access
Figure S4 from Inhibition of LILRB2 by a Novel Blocking Antibody Designed to Reprogram Immunosuppressive Macrophages to Drive T-Cell Activation in Tumors
by Ben Umiker, Yasmin Hashambhoy-Ramsay, Jeff Smith, Tanzila Rahman, Amy Mueller, Rachel Davidson, Christina Meyer, Gayatri Patankar, Mohammad Murshid Alam, Sarah Jaffe, et al.
Example gating strategy in vitro differentiated M-CSF macrophages
Open Access
Website
Google Scholar
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Figure S2 from Inhibition of LILRB2 by a Novel Blocking Antibody Designed to Reprogram Immunosuppressive Macrophages to Drive T-Cell Activation in Tumors
by Ben Umiker, Yasmin Hashambhoy-Ramsay, Jeff Smith, Tanzila Rahman, Amy Mueller, Rachel Davidson, Christina Meyer, Gayatri Patankar, Mohammad Murshid Alam, Sarah Jaffe, et al.
Example gating strategy for tumor samples in order to acquire CD163 and LILRB2 + cells
Website
Google Scholar
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Open Access
Figure S2 from Inhibition of LILRB2 by a Novel Blocking Antibody Designed to Reprogram Immunosuppressive Macrophages to Drive T-Cell Activation in Tumors
by Ben Umiker, Yasmin Hashambhoy-Ramsay, Jeff Smith, Tanzila Rahman, Amy Mueller, Rachel Davidson, Christina Meyer, Gayatri Patankar, Mohammad Murshid Alam, Sarah Jaffe, et al.
Example gating strategy for tumor samples in order to acquire CD163 and LILRB2 + cells
Open Access
Website
Google Scholar
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Figure S6 from Inhibition of LILRB2 by a Novel Blocking Antibody Designed to Reprogram Immunosuppressive Macrophages to Drive T-Cell Activation in Tumors
by Ben Umiker, Yasmin Hashambhoy-Ramsay, Jeff Smith, Tanzila Rahman, Amy Mueller, Rachel Davidson, Christina Meyer, Gayatri Patankar, Mohammad Murshid Alam, Sarah Jaffe, et al.
A Neutrophil activation assay which measures the frequency CD11b high expression by flow on neutrophils isolated from whole blood
Website
Google Scholar
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Open Access
Figure S6 from Inhibition of LILRB2 by a Novel Blocking Antibody Designed to Reprogram Immunosuppressive Macrophages to Drive T-Cell Activation in Tumors
by Ben Umiker, Yasmin Hashambhoy-Ramsay, Jeff Smith, Tanzila Rahman, Amy Mueller, Rachel Davidson, Christina Meyer, Gayatri Patankar, Mohammad Murshid Alam, Sarah Jaffe, et al.
A Neutrophil activation assay which measures the frequency CD11b high expression by flow on neutrophils isolated from whole blood
Open Access
Website
Google Scholar
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Figure S10 from Inhibition of LILRB2 by a Novel Blocking Antibody Designed to Reprogram Immunosuppressive Macrophages to Drive T-Cell Activation in Tumors
by Ben Umiker, Yasmin Hashambhoy-Ramsay, Jeff Smith, Tanzila Rahman, Amy Mueller, Rachel Davidson, Christina Meyer, Gayatri Patankar, Mohammad Murshid Alam, Sarah Jaffe, et al.
Pembrolizumab pharmacodynamic response in histoculture as measured by IFN gamma signature score
Website
Google Scholar
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Open Access
Figure S10 from Inhibition of LILRB2 by a Novel Blocking Antibody Designed to Reprogram Immunosuppressive Macrophages to Drive T-Cell Activation in Tumors
by Ben Umiker, Yasmin Hashambhoy-Ramsay, Jeff Smith, Tanzila Rahman, Amy Mueller, Rachel Davidson, Christina Meyer, Gayatri Patankar, Mohammad Murshid Alam, Sarah Jaffe, et al.
Pembrolizumab pharmacodynamic response in histoculture as measured by IFN gamma signature score
Open Access
Website
Google Scholar
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Figure S1 from Inhibition of LILRB2 by a Novel Blocking Antibody Designed to Reprogram Immunosuppressive Macrophages to Drive T-Cell Activation in Tumors
by Ben Umiker, Yasmin Hashambhoy-Ramsay, Jeff Smith, Tanzila Rahman, Amy Mueller, Rachel Davidson, Christina Meyer, Gayatri Patankar, Mohammad Murshid Alam, Sarah Jaffe, et al.
Tumor samples used in flow cytometry analysis, in this table the tumor type, the pathology, the total events and the number of CD11b+ cells are shown
Website
Google Scholar
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Open Access
Figure S1 from Inhibition of LILRB2 by a Novel Blocking Antibody Designed to Reprogram Immunosuppressive Macrophages to Drive T-Cell Activation in Tumors
by Ben Umiker, Yasmin Hashambhoy-Ramsay, Jeff Smith, Tanzila Rahman, Amy Mueller, Rachel Davidson, Christina Meyer, Gayatri Patankar, Mohammad Murshid Alam, Sarah Jaffe, et al.
Tumor samples used in flow cytometry analysis, in this table the tumor type, the pathology, the total events and the number of CD11b+ cells are shown
Open Access
Website
Google Scholar
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Figure S9 from Inhibition of LILRB2 by a Novel Blocking Antibody Designed to Reprogram Immunosuppressive Macrophages to Drive T-Cell Activation in Tumors
by Ben Umiker, Yasmin Hashambhoy-Ramsay, Jeff Smith, Tanzila Rahman, Amy Mueller, Rachel Davidson, Christina Meyer, Gayatri Patankar, Mohammad Murshid Alam, Sarah Jaffe, et al.
Sensitivity of LILRB2 as a predictive biomarker for pharmacodynamic response as measured by the macrophage polarization score in histoculture explant cultures.
Website
Google Scholar
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Open Access
Figure S9 from Inhibition of LILRB2 by a Novel Blocking Antibody Designed to Reprogram Immunosuppressive Macrophages to Drive T-Cell Activation in Tumors
by Ben Umiker, Yasmin Hashambhoy-Ramsay, Jeff Smith, Tanzila Rahman, Amy Mueller, Rachel Davidson, Christina Meyer, Gayatri Patankar, Mohammad Murshid Alam, Sarah Jaffe, et al.
Sensitivity of LILRB2 as a predictive biomarker for pharmacodynamic response as measured by the macrophage polarization score in histoculture explant cultures.

Show all